PA
ASAN icon

PharVision Advisers’s Asana ASAN Stock Holding History

PharVision Advisers’s Portfolio ASAN Stock Details ASAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.2K Sell
10,309
-8,432
-45% -$56.6K 1.36% 41
2026
Q1 		$120K Sell
18,741
-30,450
-62% -$268K 1.22% 33
2025
Q4 		$674K Buy
49,191
+32,877
+202% +$452K 0.34% 4
2025
Q3 		$218K Buy
16,314
+6,191
+61% +$87.5K 0.12% 440
2025
Q2 		$137K Buy
+10,123
New +$159K 0.2% 237

Other funds holding ASAN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

PharVision Advisers's ASAN Position: Q2 2026 in Review

PharVision Advisers reduced its Asana (ASAN) stake by 45% in Q2 2026, selling an estimated $56.6K and leaving 10,309 shares worth $72.2K. The position accounts for 1.36% of the portfolio, ranked #41.

PharVision Advisers first reported a position in ASAN in Q2 2025 and has held it in 5 quarters since. The position peaked at $674K in Q4 2025. 262 funds tracked by Wall St. Rank hold ASAN as of Q2 2026.

  • PharVision Advisers held 10,309 shares of Asana worth $72.2K as of Q2 2026.
  • PharVision Advisers sold 8,432 Asana shares in Q2 2026, an estimated $56.6K.
  • Asana made up 1.36% of PharVision Advisers's portfolio in Q2 2026, its #41 holding.
  • PharVision Advisers first reported a position in Asana in Q2 2025 and has held it in 5 quarters since.
  • PharVision Advisers's Asana position peaked at $674K in Q4 2025.
  • 262 funds tracked by Wall St. Rank held Asana as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.